From [CHD] The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,119,063 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and Feb. 11, 2022, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.

The data included a total of 23,990 reports of deaths — an increase of 375 over the previous week — and 192,517 reports of serious injuries, including deaths, during the same time period — up 4,382 compared with the previous week.

Excluding “foreign reports” to VAERS, 760,102 adverse events, including 10,909 deaths and 79,111 serious injuries, were reported in the U.S. between Dec. 14, 2020, and Feb. 11, 2022.

Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.

Of the 10,909 U.S. deaths reported as of Feb. 11, 18% occurred within 24 hours of vaccination, 23% occurred within 48 hours of vaccination and 60% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.

In the U.S., 546 million COVID vaccine doses had been administered as of Feb. 11, including 321 million doses of Pfizer, 206 million doses of Moderna and 18 million doses of Johnson & Johnson (J&J).

Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed. Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.

U.S. VAERS data from Dec. 14, 2020, to Feb. 11, 2022, for 5- to 11-year-olds show:

• 8,173 adverse events, including 179 rated as serious and 3 reported deaths.

The most recent death involves a 7-year-old girl (VAERS I.D. 1975356) from Minnesota who died 11 days after receiving her first dose of Pfizer’s COVID vaccine when she was found unresponsive by her mother. An autopsy is pending.

• 16 reports of myocarditis and pericarditis (heart inflammation).

• 29 reports of blood clotting disorders.

U.S. VAERS data from Dec. 14, 2020, to Feb. 11, 2022, for 12- to 17-year-olds show:

• 29,154 adverse events, including 1,675 rated as serious and 38 reported deaths.

The most recent deaths involve a 13-year-old male (VAERS I.D. 2042005) from an unidentified state who died from a sudden heart attack seven months after receiving his second dose of Moderna, and a 17-year-old female from an unidentified state (VAERS I.D. 2039111) who died after receiving her first dose of Moderna. Medical information was limited and it is unknown if an autopsy was performed in either case.

• 68 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 96% of cases attributed to Pfizer’s vaccine.

• 639 reports of myocarditis and pericarditis with 627 cases attributed to Pfizer’s vaccine.

• 158 reports of blood clotting disorders, with all cases attributed to Pfizer.

U.S. VAERS data from Dec. 14, 2020, to Feb. 11, 2022, for all age groups combined, show:

• 19% of deaths were related to cardiac disorders.

• 54% of those who died were male, 41% were female and the remaining death reports did not include the gender of the deceased.

• The average age of death was 72.7.

• As of Feb. 11, 5,086 pregnant women reported adverse events related to COVID vaccines, including 1,635 reports of miscarriage or premature birth.

• Of the 3,557 cases of Bell’s Palsy reported, 51% were attributed to Pfizer vaccinations, 40% to Moderna and 8% to J&J.

• 851 reports of Guillain-Barré syndrome (GBS), with 40% of cases attributed to Pfizer, 30% to Moderna and 28% to J&J.

• 2,323 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.

• 1,592 reports of myocardial infarction.

• 13,102 reports of blood clotting disorders in the U.S. Of those, 5,846 reports were attributed to Pfizer, 4,670 reports to Moderna and 2,542 reports to J&J.

• 3,992 cases of myocarditis and pericarditis with 2,456 cases attributed to Pfizer, 1,335 cases to Moderna and 170 cases to J&J’s COVID vaccine.